FierceBiotech November 25, 2025

<a href="https://www.fiercebiotech.com/pharma/gsks-tesaro-and-licensor-anaptysbio-lock-horns-court-over-jemperli-agreement" hreflang="en">GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement</a>

Some four years into Jemperli’s commercial life span, a rift has emerged between GSK subsidiary Tesaro and the potential cancer blockbuster’s original developer, AnaptysBio.